Trial Profile
Cellular immunity in adult Hepatitis B-vaccinated serologic non-responders
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Hepatitis A-hepatitis B vaccine (Primary)
- Indications Hepatitis A; Hepatitis B
- Focus Pharmacodynamics
- 25 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 25 Jun 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 13 Oct 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).